Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study

CM Segeren; Pieter Sonneveld; Ronnie van der Holt; E Vellenga; AJ Croockewit; GEG Verhoef; Jan Cornelissen; MR Schaafsma; MHJ van Oers; PW Wijermans; WE Fibbe; S Wittebol; HC (Harry) Schouten; M van Marwijk Kooy; DH Biesma; JW Baars; RM Slater; MMC Steijaert; Ivonne Buijt; HM Lokhorst

doi:10.1182/blood-2002-03-0889

Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study

CM Segeren
, Pieter Sonneveld
, Ronnie van der Holt
, E Vellenga
, AJ Croockewit
, GEG Verhoef
, Jan Cornelissen
, MR Schaafsma
, MHJ van Oers
, PW Wijermans
, WE Fibbe
, S Wittebol
, HC (Harry) Schouten
, M van Marwijk Kooy
, DH Biesma
, JW Baars
, RM Slater
, MMC Steijaert
, Ivonne Buijt
, HM Lokhorst

External organisation
Erasmus University Medical Centre

Research output: Contribution to journal › Article › Academic › peer-review

143 Citations (Scopus)

50 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	2144-2151
Number of pages	8
Journal	Blood
Volume	101
Issue number	6
DOIs	https://doi.org/10.1182/blood-2002-03-0889
Publication status	Published - 2003

Research programs

EMC MM-02-41-03

Access to Document

10.1182/blood-2002-03-0889

12456509.pdfFinal published version, 83.5 KB

http://hdl.handle.net/1765/8236

Cite this

Segeren, CM., Sonneveld, P., van der Holt, R., Vellenga, E., Croockewit, AJ., Verhoef, GEG., Cornelissen, J., Schaafsma, MR., van Oers, MHJ., Wijermans, PW., Fibbe, WE., Wittebol, S., Schouten, HC., van Marwijk Kooy, M., Biesma, DH., Baars, JW., Slater, RM., Steijaert, MMC., Buijt, I., & Lokhorst, HM. (2003). Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study. Blood, 101(6), 2144-2151. https://doi.org/10.1182/blood-2002-03-0889

@article{7bbb560a544b4d3ea265620c7783b9e7,

title = "Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study",

author = "CM Segeren and Pieter Sonneveld and \{van der Holt\}, Ronnie and E Vellenga and AJ Croockewit and GEG Verhoef and Jan Cornelissen and MR Schaafsma and \{van Oers\}, MHJ and PW Wijermans and WE Fibbe and S Wittebol and Schouten, \{HC (Harry)\} and \{van Marwijk Kooy\}, M and DH Biesma and JW Baars and RM Slater and MMC Steijaert and Ivonne Buijt and HM Lokhorst",

year = "2003",

doi = "10.1182/blood-2002-03-0889",

language = "Undefined/Unknown",

volume = "101",

pages = "2144--2151",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier",

number = "6",

}

Segeren, CM, Sonneveld, P , van der Holt, R, Vellenga, E, Croockewit, AJ, Verhoef, GEG, Cornelissen, J, Schaafsma, MR, van Oers, MHJ, Wijermans, PW, Fibbe, WE, Wittebol, S, Schouten, HC, van Marwijk Kooy, M, Biesma, DH, Baars, JW, Slater, RM, Steijaert, MMC, Buijt, I & Lokhorst, HM 2003, 'Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study', Blood, vol. 101, no. 6, pp. 2144-2151. https://doi.org/10.1182/blood-2002-03-0889

Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study. / Segeren, CM; Sonneveld, Pieter ; van der Holt, Ronnie et al.
In: Blood, Vol. 101, No. 6, 2003, p. 2144-2151.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study

AU - Segeren, CM

AU - Sonneveld, Pieter

AU - van der Holt, Ronnie

AU - Vellenga, E

AU - Croockewit, AJ

AU - Verhoef, GEG

AU - Cornelissen, Jan

AU - Schaafsma, MR

AU - van Oers, MHJ

AU - Wijermans, PW

AU - Fibbe, WE

AU - Wittebol, S

AU - Schouten, HC (Harry)

AU - van Marwijk Kooy, M

AU - Biesma, DH

AU - Baars, JW

AU - Slater, RM

AU - Steijaert, MMC

AU - Buijt, Ivonne

AU - Lokhorst, HM

PY - 2003

Y1 - 2003

U2 - 10.1182/blood-2002-03-0889

DO - 10.1182/blood-2002-03-0889

M3 - Article

C2 - 12456509

SN - 0006-4971

VL - 101

SP - 2144

EP - 2151

JO - Blood

JF - Blood

IS - 6

ER -